A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.

MLA

Lombardo, Flavia L., et al. “A Randomized Double-Blind Clinical Trial on Safety and Efficacy of Tauroursodeoxycholic Acid (TUDCA) as Add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS): The Statistical Analysis Plan of TUDCA-ALS Trial.” Trials, vol. 24, no. 1, Dec. 2023, p. 792. EBSCOhost, https://doi.org/10.1186/s13063-023-07638-w.

APA

Lombardo, F. L., Spila Alegiani, S., Mayer, F., Cipriani, M., Lo Giudice, M., Ludolph, A. C., McDermott, C. J., Corcia, P., Van Damme, P., Van den Berg, L. H., Hardiman, O., Nicolini, G., Vanacore, N., Dickie, B., Albanese, A., & Puopolo, M. (2023). A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. Trials, 24(1), 792. https://doi.org/10.1186/s13063-023-07638-w

Chicago

Lombardo, Flavia L, Stefania Spila Alegiani, Flavia Mayer, Marta Cipriani, Maria Lo Giudice, Albert Christian Ludolph, Christopher J McDermott, et al. 2023. “A Randomized Double-Blind Clinical Trial on Safety and Efficacy of Tauroursodeoxycholic Acid (TUDCA) as Add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS): The Statistical Analysis Plan of TUDCA-ALS Trial.” Trials 24 (1): 792. doi:10.1186/s13063-023-07638-w.